
An Automatic Coagulation System refers to a medical or laboratory device used to monitor and regulate the process of blood clotting, also known as coagulation. Blood clotting is a crucial physiological mechanism that prevents excessive bleeding when blood vessels are damaged. However, when this process is disrupted, it can lead to serious health issues such as excessive bleeding or clot formation.
The global Automatic Coagulation System market is projected to reach US$ 3493.6 million in 2029, increasing from US$ 2036.2 million in 2022, with the CAGR of 6.4% during the period of 2023 to 2029.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Automatic Coagulation System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
TECO Medical Instruments Production
Sysmex Corporation
Kommanditgesellschaft Behnk Elektronik GmbH & Co.
Sekisui Medical Co., Ltd.
Beckman Coulter
HORIBA Medical
Grifols
MRC group
Siemens
Biobase Biodusty
Roche Diagnostics
Abbott
Nihon Kohden
Thermo Fisher Scientific
Segment by Type
Less than 400 PT tests/hour
Above 400 PT tests/hour
Segment by Application
Hospital
Biotechnology Company
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Automatic Coagulation System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Âé¶¹Ô´´ Channel and Customer Analysis
Chapter 8: Âé¶¹Ô´´ Opportunities and Challenges
Chapter 9: Âé¶¹Ô´´ Conclusions
Chapter 10: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Automatic Coagulation System Âé¶¹Ô´´ Overview
1.1 Product Overview and Scope of Automatic Coagulation System
1.2 Automatic Coagulation System Segment by Type
1.2.1 Global Automatic Coagulation System Âé¶¹Ô´´ Value Comparison by Type (2023-2029)
1.2.2 Less than 400 PT tests/hour
1.2.3 Above 400 PT tests/hour
1.3 Automatic Coagulation System Segment by Application
1.3.1 Global Automatic Coagulation System Âé¶¹Ô´´ Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Biotechnology Company
1.3.4 Clinic
1.3.5 Others
1.4 Global Automatic Coagulation System Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global Automatic Coagulation System Revenue 2018-2029
1.4.2 Global Automatic Coagulation System Sales 2018-2029
1.4.3 Global Automatic Coagulation System Âé¶¹Ô´´ Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Automatic Coagulation System Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global Automatic Coagulation System Sales Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.2 Global Automatic Coagulation System Revenue Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.3 Global Automatic Coagulation System Average Price by Manufacturers (2018-2023)
2.4 Global Automatic Coagulation System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Automatic Coagulation System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Automatic Coagulation System, Product Type & Application
2.7 Automatic Coagulation System Âé¶¹Ô´´ Competitive Situation and Trends
2.7.1 Automatic Coagulation System Âé¶¹Ô´´ Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Automatic Coagulation System Players Âé¶¹Ô´´ Share by Revenue
2.7.3 Global Automatic Coagulation System Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Automatic Coagulation System Retrospective Âé¶¹Ô´´ Scenario by Region
3.1 Global Automatic Coagulation System Âé¶¹Ô´´ Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Automatic Coagulation System Global Automatic Coagulation System Sales by Region: 2018-2029
3.2.1 Global Automatic Coagulation System Sales by Region: 2018-2023
3.2.2 Global Automatic Coagulation System Sales by Region: 2024-2029
3.3 Global Automatic Coagulation System Global Automatic Coagulation System Revenue by Region: 2018-2029
3.3.1 Global Automatic Coagulation System Revenue by Region: 2018-2023
3.3.2 Global Automatic Coagulation System Revenue by Region: 2024-2029
3.4 North America Automatic Coagulation System Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America Automatic Coagulation System Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Automatic Coagulation System Sales by Country (2018-2029)
3.4.3 North America Automatic Coagulation System Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Automatic Coagulation System Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe Automatic Coagulation System Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Automatic Coagulation System Sales by Country (2018-2029)
3.5.3 Europe Automatic Coagulation System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Automatic Coagulation System Âé¶¹Ô´´ Facts & Figures by Country
3.6.1 Asia Pacific Automatic Coagulation System Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Automatic Coagulation System Sales by Country (2018-2029)
3.6.3 Asia Pacific Automatic Coagulation System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Automatic Coagulation System Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America Automatic Coagulation System Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Automatic Coagulation System Sales by Country (2018-2029)
3.7.3 Latin America Automatic Coagulation System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Automatic Coagulation System Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa Automatic Coagulation System Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Automatic Coagulation System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Automatic Coagulation System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Automatic Coagulation System Sales by Type (2018-2029)
4.1.1 Global Automatic Coagulation System Sales by Type (2018-2023)
4.1.2 Global Automatic Coagulation System Sales by Type (2024-2029)
4.1.3 Global Automatic Coagulation System Sales Âé¶¹Ô´´ Share by Type (2018-2029)
4.2 Global Automatic Coagulation System Revenue by Type (2018-2029)
4.2.1 Global Automatic Coagulation System Revenue by Type (2018-2023)
4.2.2 Global Automatic Coagulation System Revenue by Type (2024-2029)
4.2.3 Global Automatic Coagulation System Revenue Âé¶¹Ô´´ Share by Type (2018-2029)
4.3 Global Automatic Coagulation System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Automatic Coagulation System Sales by Application (2018-2029)
5.1.1 Global Automatic Coagulation System Sales by Application (2018-2023)
5.1.2 Global Automatic Coagulation System Sales by Application (2024-2029)
5.1.3 Global Automatic Coagulation System Sales Âé¶¹Ô´´ Share by Application (2018-2029)
5.2 Global Automatic Coagulation System Revenue by Application (2018-2029)
5.2.1 Global Automatic Coagulation System Revenue by Application (2018-2023)
5.2.2 Global Automatic Coagulation System Revenue by Application (2024-2029)
5.2.3 Global Automatic Coagulation System Revenue Âé¶¹Ô´´ Share by Application (2018-2029)
5.3 Global Automatic Coagulation System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 TECO Medical Instruments Production
6.1.1 TECO Medical Instruments Production Corporation Information
6.1.2 TECO Medical Instruments Production Description and Business Overview
6.1.3 TECO Medical Instruments Production Automatic Coagulation System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 TECO Medical Instruments Production Automatic Coagulation System Product Portfolio
6.1.5 TECO Medical Instruments Production Recent Developments/Updates
6.2 Sysmex Corporation
6.2.1 Sysmex Corporation Corporation Information
6.2.2 Sysmex Corporation Description and Business Overview
6.2.3 Sysmex Corporation Automatic Coagulation System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sysmex Corporation Automatic Coagulation System Product Portfolio
6.2.5 Sysmex Corporation Recent Developments/Updates
6.3 Kommanditgesellschaft Behnk Elektronik GmbH & Co.
6.3.1 Kommanditgesellschaft Behnk Elektronik GmbH & Co. Corporation Information
6.3.2 Kommanditgesellschaft Behnk Elektronik GmbH & Co. Description and Business Overview
6.3.3 Kommanditgesellschaft Behnk Elektronik GmbH & Co. Automatic Coagulation System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Kommanditgesellschaft Behnk Elektronik GmbH & Co. Automatic Coagulation System Product Portfolio
6.3.5 Kommanditgesellschaft Behnk Elektronik GmbH & Co. Recent Developments/Updates
6.4 Sekisui Medical Co., Ltd.
6.4.1 Sekisui Medical Co., Ltd. Corporation Information
6.4.2 Sekisui Medical Co., Ltd. Description and Business Overview
6.4.3 Sekisui Medical Co., Ltd. Automatic Coagulation System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sekisui Medical Co., Ltd. Automatic Coagulation System Product Portfolio
6.4.5 Sekisui Medical Co., Ltd. Recent Developments/Updates
6.5 Beckman Coulter
6.5.1 Beckman Coulter Corporation Information
6.5.2 Beckman Coulter Description and Business Overview
6.5.3 Beckman Coulter Automatic Coagulation System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Beckman Coulter Automatic Coagulation System Product Portfolio
6.5.5 Beckman Coulter Recent Developments/Updates
6.6 HORIBA Medical
6.6.1 HORIBA Medical Corporation Information
6.6.2 HORIBA Medical Description and Business Overview
6.6.3 HORIBA Medical Automatic Coagulation System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 HORIBA Medical Automatic Coagulation System Product Portfolio
6.6.5 HORIBA Medical Recent Developments/Updates
6.7 Grifols
6.6.1 Grifols Corporation Information
6.6.2 Grifols Description and Business Overview
6.6.3 Grifols Automatic Coagulation System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Grifols Automatic Coagulation System Product Portfolio
6.7.5 Grifols Recent Developments/Updates
6.8 MRC group
6.8.1 MRC group Corporation Information
6.8.2 MRC group Description and Business Overview
6.8.3 MRC group Automatic Coagulation System Sales, Revenue and Gross Margin (2018-2023)
6.8.4 MRC group Automatic Coagulation System Product Portfolio
6.8.5 MRC group Recent Developments/Updates
6.9 Siemens
6.9.1 Siemens Corporation Information
6.9.2 Siemens Description and Business Overview
6.9.3 Siemens Automatic Coagulation System Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Siemens Automatic Coagulation System Product Portfolio
6.9.5 Siemens Recent Developments/Updates
6.10 Biobase Biodusty
6.10.1 Biobase Biodusty Corporation Information
6.10.2 Biobase Biodusty Description and Business Overview
6.10.3 Biobase Biodusty Automatic Coagulation System Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Biobase Biodusty Automatic Coagulation System Product Portfolio
6.10.5 Biobase Biodusty Recent Developments/Updates
6.11 Roche Diagnostics
6.11.1 Roche Diagnostics Corporation Information
6.11.2 Roche Diagnostics Automatic Coagulation System Description and Business Overview
6.11.3 Roche Diagnostics Automatic Coagulation System Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Roche Diagnostics Automatic Coagulation System Product Portfolio
6.11.5 Roche Diagnostics Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Corporation Information
6.12.2 Abbott Automatic Coagulation System Description and Business Overview
6.12.3 Abbott Automatic Coagulation System Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Abbott Automatic Coagulation System Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Nihon Kohden
6.13.1 Nihon Kohden Corporation Information
6.13.2 Nihon Kohden Automatic Coagulation System Description and Business Overview
6.13.3 Nihon Kohden Automatic Coagulation System Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Nihon Kohden Automatic Coagulation System Product Portfolio
6.13.5 Nihon Kohden Recent Developments/Updates
6.14 Thermo Fisher Scientific
6.14.1 Thermo Fisher Scientific Corporation Information
6.14.2 Thermo Fisher Scientific Automatic Coagulation System Description and Business Overview
6.14.3 Thermo Fisher Scientific Automatic Coagulation System Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Thermo Fisher Scientific Automatic Coagulation System Product Portfolio
6.14.5 Thermo Fisher Scientific Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Automatic Coagulation System Industry Chain Analysis
7.2 Automatic Coagulation System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Automatic Coagulation System Production Mode & Process
7.4 Automatic Coagulation System Sales and Âé¶¹Ô´´ing
7.4.1 Automatic Coagulation System Sales Channels
7.4.2 Automatic Coagulation System Distributors
7.5 Automatic Coagulation System Customers
8 Automatic Coagulation System Âé¶¹Ô´´ Dynamics
8.1 Automatic Coagulation System Industry Trends
8.2 Automatic Coagulation System Âé¶¹Ô´´ Drivers
8.3 Automatic Coagulation System Âé¶¹Ô´´ Challenges
8.4 Automatic Coagulation System Âé¶¹Ô´´ Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TECO Medical Instruments Production
Sysmex Corporation
Kommanditgesellschaft Behnk Elektronik GmbH & Co.
Sekisui Medical Co., Ltd.
Beckman Coulter
HORIBA Medical
Grifols
MRC group
Siemens
Biobase Biodusty
Roche Diagnostics
Abbott
Nihon Kohden
Thermo Fisher Scientific
Ìý
Ìý
*If Applicable.
